Wall Street CN reports Phase 3 results for BL-B01D1 in HR+HER2- breast cancer published in The Lancet
Briefing by News4U · First published
Wall Street CN reports that the Phase 3 PANKU-Breast01 trial results for BL-B01D1 in HR+HER2- advanced breast cancer were presented and published in The Lancet.
Wall Street CN reports that the Phase 3 PANKU-Breast01 trial results for BL-B01D1 (iza-bren) in HR+HER2- advanced breast cancer were presented as a Late-breaking Abstract and simultaneously published in full in The Lancet. [1]
Sources
- 快讯
Wall Street CN · · Full text